SCHEMBL7400566

SCHEMBL7400566

CC(C)(C)OC(=O)NCCCOc1cc(C(=O)O)on1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.46
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
CA9 Q16790 6/20 0.46
SMPD1 P17405 1/20 0.45
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP1A1 P04798 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYP3A43 Q9HB55 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
STK17B O94768 1/20 0.41
STK17A Q9UEE5 1/20 0.41
SUCNR1 Q9BXA5 1/20 0.41
IDO1 P14902 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GABRA5 P31644 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8650087 0.96 CA12 (0.44) CA12CA1CA2CA9SMPD1
SCHEMBL7403280 0.89 CA12 (0.45) CA12CA1CA2CA9SMPD1
SCHEMBL7401023 0.81 SMPD1 (0.45) CA12CA1CA2CA9SMPD1
SCHEMBL28442714 0.79 CA12 (0.47) CA12CA1CA2CA9CYP1A1
SCHEMBL28897428 0.79 CA12 (0.47) CA12CA1CA2CA9GAA
SCHEMBL2411780 0.79 NPSR1 (0.44) CA1CA2MEN1GAAKMT2A
SCHEMBL8378941 0.78 GABRA5 (0.46) CA12CA1CA2CA9KMT2A
SCHEMBL7453137 0.77 LMNA (0.46) SMPD1MAPTHTT
SCHEMBL9111613 0.77 ATM (0.37) CA1CA2SMPD1MEN1KMT2A
SCHEMBL31152712 0.77 CA12 (0.41) CA12CA1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828737-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-18 EP disclosed
US-5710159-A IMIDAZOLIN-2-YLAMINOPROPOXY)ISOXAZOL-5-CARBONYLAMINO-2 -BENZYLOXYCARBONYLAMINOPROPIONIC ACID AS ANTIINFLAMMATORY AGENTS, BONE DEGRADATION, TUMORS, METASTASES AND THROMBOSIS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-20 US disclosed
WO-1996037492-A1 ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-11-28 WO disclosed